|
JPS4829785B1
(enExample)
|
1970-03-26 |
1973-09-13 |
|
|
|
BE787766A
(fr)
*
|
1971-08-21 |
1973-02-19 |
Merck Patent Gmbh |
Imides d'acide glutarique et leur procede de preparation
|
|
US4063019A
(en)
|
1976-03-30 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
[[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives
|
|
US4304715A
(en)
|
1979-06-08 |
1981-12-08 |
Derek Hudson |
Enkephalin analogues
|
|
DE3027596A1
(de)
|
1980-07-21 |
1982-02-18 |
Bayer Ag, 5090 Leverkusen |
Triazolidin-3,5-dion-oxyalkylverbindungen und verfahren zu ihrer herstellung
|
|
JPS5839672A
(ja)
|
1981-09-03 |
1983-03-08 |
Chugai Pharmaceut Co Ltd |
ウラシル誘導体
|
|
JPS60243017A
(ja)
|
1984-05-16 |
1985-12-03 |
Kyowa Hakko Kogyo Co Ltd |
抗けいれん組成物
|
|
JPH0674251B2
(ja)
|
1986-02-07 |
1994-09-21 |
全薬工業株式▲会▼社 |
ビス−ジオキソピペラジン誘導体
|
|
JPS63101361A
(ja)
*
|
1986-09-08 |
1988-05-06 |
ブリティッシュ・テクノロジー・グループ・リミテッド |
ジオキソピペリジン誘導体を含有する不安解消組成物
|
|
FR2644786B1
(fr)
|
1989-03-21 |
1993-12-31 |
Adir Cie |
Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5463063A
(en)
*
|
1993-07-02 |
1995-10-31 |
Celgene Corporation |
Ring closure of N-phthaloylglutamines
|
|
US5599796A
(en)
|
1993-12-02 |
1997-02-04 |
Emory University |
Treatment of urogenital cancer with boron neutron capture therapy
|
|
CA2200964A1
(en)
|
1994-11-24 |
1996-05-30 |
Takeda Chemical Industries, Ltd. |
Alpha-ketoamide derivatives as cathepsin l inhibitor
|
|
US5962246A
(en)
|
1996-03-29 |
1999-10-05 |
The University Of Medicine And Dentistry Of New Jersey |
dUTPase, its isoforms, and diagnostic and other uses
|
|
JPH09286786A
(ja)
|
1996-04-18 |
1997-11-04 |
Nippon Paper Ind Co Ltd |
ピリミジン誘導体及びその抗腫瘍剤としての用途
|
|
DE19756212A1
(de)
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide
|
|
WO1999031066A1
(en)
|
1997-12-18 |
1999-06-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyridones as src family sh2 domain inhibitors
|
|
EP1165500A1
(en)
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
DE10002509A1
(de)
*
|
2000-01-21 |
2001-07-26 |
Gruenenthal Gmbh |
Substituierte Glutarimide
|
|
KR20030082990A
(ko)
|
2001-03-15 |
2003-10-23 |
아스트라제네카 아베 |
메탈로프로테이나제 억제제
|
|
JP2002284686A
(ja)
|
2001-03-28 |
2002-10-03 |
Sankyo Co Ltd |
スルホンアミド化合物を含有する医薬組成物
|
|
JP2004527535A
(ja)
|
2001-04-11 |
2004-09-09 |
クイーンズ ユニバーシティ アット キングストン |
抗発作発生剤および／または抗癲癇誘発剤としてのピリミジン化合物
|
|
US6822097B1
(en)
*
|
2002-02-07 |
2004-11-23 |
Amgen, Inc. |
Compounds and methods of uses
|
|
WO2004009559A2
(en)
|
2002-07-18 |
2004-01-29 |
Queen's University At Kingston |
Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
|
|
US7125865B2
(en)
|
2002-07-25 |
2006-10-24 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
GB0221246D0
(en)
|
2002-09-13 |
2002-10-23 |
Astrazeneca Ab |
Compounds
|
|
GB0400290D0
(en)
|
2004-01-08 |
2004-02-11 |
Medivir Ab |
dUTPase inhibitors
|
|
EP1848433A2
(en)
|
2005-01-25 |
2007-10-31 |
Celgene Corporation |
Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
|
|
WO2006135763A2
(en)
|
2005-06-09 |
2006-12-21 |
The Johns Hopkins University |
Inhibitors of dna repair enzymes and methods of use thereof
|
|
KR20110089463A
(ko)
|
2006-07-24 |
2011-08-08 |
한국화학연구원 |
신규 ｈｉｖ 역전사 효소 억제제
|
|
EP1939186A1
(en)
|
2006-12-22 |
2008-07-02 |
Sulfidris S.r.l. |
5-Fluorouracil derivatives and their use for the treatment of cancer
|
|
CL2008003651A1
(es)
|
2007-12-10 |
2009-06-19 |
Novartis Ag |
Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
|
|
US8530490B2
(en)
|
2008-06-03 |
2013-09-10 |
Taiho Pharmaceutical Co., Ltd. |
Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
|
|
US20110212467A1
(en)
|
2008-08-27 |
2011-09-01 |
University Of Southern California |
INHIBITORS OF dUTPase
|
|
JP2011231015A
(ja)
*
|
2008-08-29 |
2011-11-17 |
Taiho Yakuhin Kogyo Kk |
含窒素複素環を有する新規ウラシル化合物又はその塩
|
|
ES2401965T3
(es)
|
2009-02-19 |
2013-04-25 |
Novo Nordisk A/S |
Modificación de Factor VIII
|
|
US8912329B2
(en)
|
2009-06-25 |
2014-12-16 |
BioVersys AG |
Composition for treatment of tuberculosis
|
|
CN103948599B
(zh)
*
|
2009-11-30 |
2016-03-09 |
大鹏药品工业株式会社 |
抗肿瘤效果增强剂
|
|
JP2013032293A
(ja)
|
2009-11-30 |
2013-02-14 |
Taiho Yakuhin Kogyo Kk |
ヒトｄＵＴＰａｓｅ阻害活性を有する５−フルオロウラシル化合物又はその塩
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
GB201020032D0
(en)
*
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
|
WO2013012848A1
(en)
|
2011-07-18 |
2013-01-24 |
Merck Patent Gmbh |
Benzamides
|
|
AU2012337781B2
(en)
|
2011-11-15 |
2017-07-06 |
Takeda Pharmaceutical Company Limited |
Dihydroxy aromatic heterocyclic compound
|
|
CA2914178C
(en)
|
2013-01-07 |
2023-06-13 |
University Of Southern California |
Deoxyuridine triphosphatase inhibitors
|
|
JP6513095B2
(ja)
|
2014-01-03 |
2019-05-15 |
ユニバーシティ オブ サザン カリフォルニア |
ヘテロ原子含有デオキシウリジントリホスファターゼ阻害剤
|
|
WO2015142001A2
(ko)
|
2014-03-21 |
2015-09-24 |
충남대학교산학협력단 |
강심 활성을 갖는 화합물 및 이를 함유하는 심부전 예방 또는 치료용 약학적 조성물
|
|
US20180110780A1
(en)
|
2015-04-30 |
2018-04-26 |
Taiho Pharmaceutical Co., Ltd. |
Agent for alleviating side effect of antitumor drug
|
|
AU2016258388B2
(en)
|
2015-05-01 |
2019-03-28 |
Taiho Pharmaceutical Co., Ltd. |
Novel crystal of uracil compound
|
|
WO2017006271A1
(en)
|
2015-07-08 |
2017-01-12 |
University Of Southern California |
Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
|
|
US10544105B2
(en)
|
2015-07-08 |
2020-01-28 |
Cv6 Therapeutics (Ni) Limited |
Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
|
|
WO2017006270A1
(en)
|
2015-07-08 |
2017-01-12 |
University Of Southern California |
Deoxyuridine triphosphatase inhibitors
|
|
PT3319939T
(pt)
|
2015-07-08 |
2025-03-05 |
Cv6 Therapeutics Ni Ltd |
Inibidores de desoxiuridina-trifosfatase contendo hidantoína
|
|
US10858344B2
(en)
|
2016-11-23 |
2020-12-08 |
Cv6 Therapeutics (Ni) Limited |
Hydantoin containing deoxyuridine triphosphatase inhibitors
|
|
WO2018098204A1
(en)
|
2016-11-23 |
2018-05-31 |
Cv6 Therapeutics (Ni) Limited |
6-membered uracil isosteres
|
|
US10829457B2
(en)
|
2016-11-23 |
2020-11-10 |
Cv6 Therapeutics (Ni) Limited |
Nitrogen ring linked deoxyuridine triphosphatase inhibitors
|
|
US11014924B2
(en)
|
2016-11-23 |
2021-05-25 |
Cv6 Therapeutics (Ni) Limited |
Hydantoin containing deoxyuridine triphosphatase inhibitors
|
|
US11168059B2
(en)
|
2016-11-23 |
2021-11-09 |
Cv6 Therapeutics (Ni) Limited |
Amino sulfonyl compounds
|
|
WO2018128720A1
(en)
|
2017-01-05 |
2018-07-12 |
Cv6 Therapeutics (Ni) Limited |
Uracil containing compounds
|